Mechanism of Action :

Capsaicin, or 6-nonenamide, N-[(4-hydroxy-3-methoxyphenyl) methyl]-8-methyl, (6E), is a highly 
selective agonist for the transient receptor potential vanilloid 1 receptor (TRPV1). The initial effect of 
capsaicin is the activation of TRPV1-expressing cutaneous nociceptors, which results in pungency and 
erythema due to the release of vasoactive neuropeptides.

Indication :

Capsaicin is indicated to 

  1. temporarily relieves minor aches and pains of muscles and joints 
  2. the treatment of peripheral neuropathic pain in adults either alone or in combination with other medicinal products for the treatment of pain.
Disclaimer
 

Please be reminded that some products listed above are still patented and can only be made available for R & D use as permitted under 35 USC ¶ 271 (e) (1); Article 69, Paragraph 1 of the Patent Act of Japan; Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004; or Article 69 (5) of the Patent Law of People’s Republic of China; or Article 60 of the Patent Act of Republic of China. We will not make, sell, offer for commercial sale or export the products listed above in/into regions or countries in which substance patents are still existing and we will not be responsible if the use of any of the above products infringes on any patent in your country.

Close